Capricor Therapeutics Inc (CAPR)
5.005
-0.04
(-0.89%)
USD |
NASDAQ |
Apr 19, 16:00
5.005
0.00 (0.00%)
After-Hours: 20:00
Capricor Therapeutics Net Income (Quarterly): -0.7621M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.7621M |
| September 30, 2023 | -6.391M |
| June 30, 2023 | -7.367M |
| March 31, 2023 | -7.768M |
| December 31, 2022 | -7.721M |
| September 30, 2022 | -6.371M |
| June 30, 2022 | -7.109M |
| March 31, 2022 | -7.818M |
| December 31, 2021 | -6.190M |
| September 30, 2021 | -3.932M |
| June 30, 2021 | -4.748M |
| March 31, 2021 | -5.152M |
| December 31, 2020 | -4.178M |
| September 30, 2020 | -3.910M |
| June 30, 2020 | -3.484M |
| March 31, 2020 | -2.085M |
| December 31, 2019 | -1.469M |
| September 30, 2019 | -1.607M |
| June 30, 2019 | -2.046M |
| March 31, 2019 | -2.519M |
| December 31, 2018 | -3.260M |
| September 30, 2018 | -4.136M |
| June 30, 2018 | -4.124M |
| March 31, 2018 | -3.672M |
| December 31, 2017 | 12.31M |
| Date | Value |
|---|---|
| September 30, 2017 | -2.735M |
| June 30, 2017 | -3.472M |
| March 31, 2017 | -3.667M |
| December 31, 2016 | -4.518M |
| September 30, 2016 | -5.333M |
| June 30, 2016 | -4.689M |
| March 31, 2016 | -4.266M |
| December 31, 2015 | -3.346M |
| September 30, 2015 | -2.912M |
| June 30, 2015 | -3.123M |
| March 31, 2015 | -3.476M |
| December 31, 2014 | -1.928M |
| September 30, 2014 | -1.544M |
| June 30, 2014 | -1.534M |
| March 31, 2014 | -1.211M |
| December 31, 2013 | -4.305M |
| September 30, 2013 | -1.545M |
| June 30, 2013 | -1.625M |
| March 31, 2013 | -1.417M |
| December 31, 2012 | -0.3802M |
| September 30, 2012 | -0.5662M |
| June 30, 2012 | -0.3529M |
| March 31, 2012 | -0.7719M |
| December 31, 2011 | -1.664M |
| September 30, 2011 | -1.144M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-7.818M
Minimum
Mar 2022
-0.7621M
Maximum
Dec 2023
-4.743M
Average
-4.748M
Median
Jun 2021
Net Income (Quarterly) Benchmarks
| Cutera Inc | -44.27M |
| Sarepta Therapeutics Inc | 45.66M |
| PTC Therapeutics Inc | -155.79M |
| Solid Biosciences Inc | -20.34M |
| AIM ImmunoTech Inc | -12.58M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 12.09M |
| Total Expenses (Quarterly) | 13.37M |
| EPS Diluted (Quarterly) | 0.02 |
| Enterprise Value | 119.60M |
| Profit Margin (Quarterly) | -6.30% |
| Earnings Yield | -16.58% |
| Normalized Earnings Yield | -17.87 |